Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
34 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2024
Endomedical from Sint-Agatha-Berchem, company number BE0741371394, closed financial year 2024 with a result of € 182,661 after tax. For that financial year Endomedical recorded a gross margin of € 299,320 and equity of € 345,182. Compared with financial year 2023, the result moved from € 68,130 to € 182,661. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 5, 2025.
€ 345,182
▲ 31% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 182,661
▲ 168% vs 2023
Profit after tax over the fiscal year.
€ 71,184
▲ 51% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 100,000 paid out
55 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2024
€ 51,545
▲ 46% vs 2023
Of which on lease € 8,836.
Debts at end 2024
€ 15,631
▼ 38% vs 2023
€ 10,274 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 5,943
▲ 6% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 121,458
▲ 182% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 109,038 | € 160,008 | € 213,090 | € 299,320 | ▲ 40% |
| Profit after taxes | € 69,178 | € 54,905 | € 68,130 | € 182,661 | ▲ 168% |
| Equity | € 239,486 | € 294,391 | € 262,521 | € 345,182 | ▲ 31% |
| Total debts | € 83,849 | € 103,847 | € 175,847 | € 243,032 | ▲ 38% |
| Cash | € 169,347 | € 216,206 | € 47,097 | € 71,184 | ▲ 51% |
| Retained profit | € 236,786 | € 291,691 | € 259,821 | € 342,482 | ▲ 32% |
| Dividend | € 0 | € 0 | € 100,000 | € 100,000 | |
| Bank debt | € 0 | € 0 | € 25,344 | € 15,631 | ▼ 38% |
| Balance sheet total | € 323,334 | € 398,237 | € 438,368 | € 588,214 | ▲ 34% |
Key figures of Endomedical, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to Endomedical?
What happened at Endomedical in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 182,661 (▲ 168% vs 2023). filed late Source: NBB ↗
- New establishment in Sint-Agatha-Berchem. KBO
- Mohamed El Koulali became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 69,178 profit in 2021 to € 182,661 profit in 2024.
Paid € 176,394 in corporate taxes since 2021.
Best year ever: 2024, with € 182,661 profit.
Paid out € 200,000 in dividends to the owners in total.
A new publication or filing at Endomedical? We notify you, reason included.
Follow EndomedicalDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Endomedical is Mohamed El Koulali.
Directors
According to the 2024 annual accounts
Mohamed El Koulali
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Groot-Bijgaardenstraat 14
1082 Sint-Agatha-Berchem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 34 companies are registered at this address.
All companies at this address →Huis Alfons Simkens
€ 53,656 gross margin · 2024
SCALP RECORDS
€ -440 gross margin · 2025
Infoma
€ -8,571 gross margin · 2023
STAES FINANCIEEL MANAGEMENT
T. & C.C. INVEST
€ 4,351 gross margin · 2023
+29 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0741.371.394
- VAT number
- BE 0741.371.394
- Registered office
- Groot-Bijgaardenstraat 14, 1082 Sint-Agatha-Berchem
- Names & denominations
- Endomedical
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 January 2020
- Peppol
- Active · Active since 4 Dec 2025